What is Spect?
Spect operates at the intersection of data science and healthcare, providing comprehensive eye disease screening solutions. The company leverages an AI-enabled telemedicine platform to offer rapid diagnostic reports, transforming the traditional multi-day process into a matter of minutes. Spect's technology not only screens for ocular conditions but also serves as a predictive indicator for systemic diseases, positioning the eye as a crucial diagnostic window for overall health. This innovative approach aims to enhance service delivery and financial outcomes for both patients and healthcare providers.
How much funding has Spect raised?
Spect has raised a total of $3.6M across 2 funding rounds:
Debt
$107K
Angel/Seed
$3.5M
Debt (2021): $107K with participation from PPP
Angel/Seed (2021): $3.5M led by 10x, Morado Ventures, XTX Ventures, and AME Cloud
Key Investors in Spect
Morado Ventures
Morado Ventures is a tech-forward seed fund that invests in exceptional founders developing transformative companies. The firm focuses on early-stage, data-driven companies addressing complex technological challenges across various sectors, including AI, industrial IoT, robotics, and health tech. Morado Ventures collaborates closely with entrepreneurs to create and implement strategies that can revolutionize industries. Their mission is to support passionate innovators who are poised to disrupt traditional markets with innovative software and hardware solutions.
10x
Undisclosed investor participating in the funding round.
XTX Ventures
Undisclosed investor participating in the funding round.
What's next for Spect?
With the recent enterprise-level backing, Spect is strategically positioned for significant growth and market expansion. The company is expected to further develop its AI capabilities, enhance its telemedicine platform, and broaden its reach within the healthcare ecosystem. This investment will likely fuel research into new predictive diagnostics for whole-body diseases, solidifying Spect's role as a leader in preventative health technology. The focus will be on scaling operations to meet the growing demand for efficient and accurate disease detection solutions.
See full Spect company page
